Jubilant Ingrevia (Mid Cap - High Growth) Share Target 2025, 2026 To 2035
|
Jubilant Ingrevia Limited |
|||
|
Price: ₹712.15 (+0.26%) | ||
| 52 Week Low: ₹420.00 52 Week High: ₹885.00 |
|||
| Market Capital: 10,484.51 Crore (Midcap) | |||
| Basic Materials -> Specialty Chemicals | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Jubilant Ingrevia Share Price Target For 2025
- 1.1.1: Jubilant Ingrevia Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: Jubilant Ingrevia Share Price Target For 2026
- 1.2.1: Jubilant Ingrevia Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Jubilant Ingrevia Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: Jubilant Ingrevia Brief Company Overview
- 4: Jubilant Ingrevia Financial Performance
- 4.0.1: Is Jubilant Ingrevia A Good Buy For Long Term?
Jubilant Ingrevia, a Mid Cap company in the Specialty Chemicals Industry has delivered 62.7% returns in 1-year showing 2.5% quarterly revenue growth with 4.3% profit margin, making it a High Growth stock.
To predict the Jubilant Ingrevia's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Jubilant Ingrevia Share Price Target For 2025
The line chart displays the monthly closing prices of Jubilant Ingrevia with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Jubilant Ingrevia shares in 2025, see the table below.
Jubilant Ingrevia Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 799.7 (+12.29%) | Price Action: 02 Dec 2024 High |
| 2025 Target 2 | 791.15 (+11.09%) | Price Action: 19 Dec 2024 Low |
| 2025 Target 1 | 783.1 (+9.96%) | Price Action: 08 Jan 2025 Low |
| Current Price | 712.15 | Jubilant Ingrevia's share price as of 17 Jan 2025 |
| Stop Loss 1 | 680.0 (-4.51%) | Price Action: Jan 2025 Low |
| Stop Loss 2 | 672.45 (-5.58%) | Price Action: 23 Aug 2024 Low |
| Stop Loss 3 | 664.5 (-6.7%) | Price Action: 18 Nov 2024 High |
Short-Term Technical Outlook
Current Technical Position: Jubilant Ingrevia is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 50-day moving average at ₹765.69 serves as the nearest technical reference point.
Historical Returns: 3-month: -0.64% | 6-month: +17.67% | 1-year: +62.67%
Jubilant Ingrevia Share Price Target For 2026
The line chart displays the monthly closing prices of Jubilant Ingrevia with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Jubilant Ingrevia shares in 2026, see the table below.
Jubilant Ingrevia Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 1089.98 (+53.05%) | Price Action: Chart |
| 2026 Target 2 | 1069.66 (+50.2%) | Price Action: Chart |
| 2026 Target 1 | 1059.07 (+48.71%) | Fibonacci Extension Level 64.90% |
| Current Price | 712.15 | Jubilant Ingrevia's share price as of 17 Jan 2025 |
| Stop Loss 1 | 630.65 (-11.45%) | Price Action: 20 Aug 2024 Low |
| Stop Loss 2 | 618.4 (-13.17%) | Price Action: 30 Jul 2024 High |
| Stop Loss 3 | 612.0 (-14.07%) | Price Action: 31 Jul 2024 High |
Long-Term Technical Outlook
52-Week Range Analysis: Jubilant Ingrevia is currently trading at 62.8% of its 52-week range (₹420 - ₹885).
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +62.67% | 3-year: +24.43% | 5-year: NA
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Jubilant Ingrevia Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹712.15 | ||
| 2025 | ₹1,053.43 | +47.92% | ₹1,069.23 |
| 2026 | ₹1,534.15 | +45.63% | ₹1,557.16 |
| 2027 | ₹2,041.30 | +33.05% | ₹2,071.92 |
| 2028 | ₹3,181.02 | +55.83% | ₹3,228.74 |
| 2029 | ₹4,039.44 | +26.98% | ₹4,100.03 |
| 2030 | ₹5,433.00 | +34.49% | ₹5,514.50 |
| 2031 | ₹6,605.51 | +21.58% | ₹6,704.59 |
| 2032 | ₹8,157.48 | +23.49% | ₹8,279.84 |
| 2033 | ₹9,982.41 | +22.37% | ₹10,132.15 |
| 2034 | ₹12,757.00 | +27.79% | ₹12,948.36 |
| 2035 | ₹16,220.54 | +27.15% | ₹16,463.85 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Jubilant Ingrevia Brief Company Overview
Company Overview Jubilant Ingrevia Limited is a global life science company based in India, incorporated in 2019. They operate in three segments: Specialty Chemicals: Pyridine, picolines, fine chemicals, crop protection chemicals, custom manufacturing Nutrition & Health...
Solutions: Nutrition and health ingredients, animal nutrition and health solutions, human nutrition and health solutions Chemical Intermediates: Acetyls, specialty ethanol The company's extensive product range serves diverse industries, including pharmaceutical, animal and human nutrition, agrochemical, personal and consumer care, and industrial. Jubilant Ingrevia Limited's commitment to innovation and quality has earned it a solid reputation in the industry.Jubilant Ingrevia Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 10,484.51 Crore | Market valuation of Jubilant Ingrevia's shares. |
| Revenue (TTM) | 4,110.41 Crore | Total revenue generated by Jubilant Ingrevia over the past twelve months. |
| Net Income (TTM) | +175.54 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +8.11% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +4.26% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+2.5% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
+2.6% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
25.56 | Company's total debt divided by total shareholder equity. |
| Total Debt | 719.68 Crore | Sum of Jubilant Ingrevia's current & long-term financial obligations. |
| Total Cash | 62.62 Crore | Total amount of liquid funds available to Jubilant Ingrevia. |
| Beta | 0.44 | Beta is less than 1 indicating that the Jubilant Ingrevia's price is less volatile than the market. |
Is Jubilant Ingrevia A Good Buy For Long Term?
No valid response content found
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
